Oxcarbazepine in combination with tiaprid in inpatient alcohol-withdrawal a RCT

Pharmacopsychiatry

Volumn 42, Issue 5, 2009, Pages 175-181

  Croissant, B ^a   Loeber, S ^b   Diehl, A ^b   Nakovics, H ^b   Wagner, F ^c   Kiefer, F ^b   Mann, K ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMETHIAZOLE; OXCARBAZEPINE; TIAPRIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DRUG DERIVATIVE;

ADULT; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BRONCHUS SECRETION; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DELIRIUM; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; DYSKINESIA; EYE PAIN; FATIGUE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE IRRITATION; OPEN STUDY; PARKINSONISM; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RHINORRHEA; SALIVATION; SEIZURE; SIDE EFFECT; SKIN TINGLING; THROAT IRRITATION; VISUAL IMPAIRMENT; DRUG COMBINATION; MIDDLE AGED; TIME; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL-RELATED DISORDERS; ANTICONVULSANTS; CARBAMAZEPINE; CHLORMETHIAZOLE; DRUG THERAPY, COMBINATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TIAPRIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350434354     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1202264     Document Type: Article

References (47)

1. Anton RF, Drobes DJ, Voronin K, etal. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology 2004 173 (12) 32-40
2. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care Second Edition, WHO/MSD/MSB/01.6a 2001
3. Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2002 3 59-71
4. Bock J. Determination of group sizes for biological experiments and controlled clinical trials [Bestimmung des Stichprobenumfangs für biologische Experimente und kontrollierte klinische Studien] Oldenbourg, München 1998
5. Book SW, Myrick H. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs 2005 14 371-376
6. Cazzato G, Gioseffi M, Torre P, etal. Prevention and therapy of delirium tremens with tiapride. Riv Neurol 1982 52 379-391
7. Croissant B, Grosshans M, Klein O, etal. Scheme-based benzodiazepine detoxification with oxcarbazepine. Pharmacopsychiatry 2005 38 222-223
8. Croissant B, Scherle T, Diehl A, etal. Oxcarbazepine in alcohol relapse prevention A case series. Pharmacopsychiatry 2004 37 306-307 (Pubitemid 39587061)
9. Croissant B, Diehl A, Klein O, etal. A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients. Alcohol Clin Exp Res 2006 30 630-635
10. Finzen A. Medikamentenbehandlung bei psychischen Störungen. [Medication treatment of mental disorders] Bonn: Psychiatrie-Verlag 1984
11. Franz M, Dlabal H, Kunz S, etal. Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazol. Eur Arch Psychiatry Clin Neurosci 2001 251 185-192
12. Furlanut M, Franceschi L, Poz D, etal. Acute oxcarbazepine, benazepril, and hydrochlorothiazide overdose with alcohol. Ther Drug Monit 2006 28 267-268
13. Glauser TA. Oxcarbazepine in the treatment of epilepsy. Pharmacotherapy 2001 21 904-919
14. Gonzalez L, Veatch L, Ticku M, etal. Alcohol withdrawal kindling: mechanisms and implications for treatment. Alcohol Clin Exp Res 2001 25 197-201
15. Hermann D, Klages E, Croissant B. Oxcarbazepine in outpatient benzodiazepine withdrawal in polytoxicomanic patients during an opiate maintenance therapy. Psychopharmakotherap 2005 12 97-99
16. Hillemacher T, Weinland C, Heberlein A, etal. Treatment with clomethiazole is associated with lower rates of premature discharge during alcohol withdrawal. Pharmacopsychiat 2008 41 134-137
17. Homberg V, Kowalik A, Schulze-Bonhage A. Ad hoc change from carbamazepine to oxcarbazepine effectiveness and tolerance. A retrospective analysis. Nervenarzt 2001 72 918-923
18. Koethe D, Juelicher A, Nolden BM, etal. Oxcarbazepine efficacy and tolerability during treatment of alcohol withdrawal. A double-blind, randomized, placebo-controlled multicenter pilot study. Alcohol Clin Exp Res 2007 31 1188-1194
19. Kosten TR, OConnor PG. Management of drug and alcohol withdrawal. N Engl J Med 2003 348 1786-1795
20. Littleton JM, De Witte P, Litten R, etal. Challenges to medications development in treating alcohol dependence: an international perspective. Alcohol Alcohol 2004 39 (4) 271-275
21. Lucht M, Kuehn KU, Armbruster J, etal. Alcohol withdrawal treatment in intoxicated vs. non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Alcohol Alcohol 2003 38 168-175
22. Lu BY, Coberly R, Bogenschutz M. Use of oxcarbazepine in outpatient alcohol detoxification. Am J Addict 2005 14 191-192
23. Majumdar SK. Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 1991 27 201-207
24. Malcolm R, Lucht M, Kuehn KU, etal. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989 146 617-621
25. Malcolm R, Myrick H, Brady KT, etal. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 2001 10 16-23
26. Malcolm R, Myrick H, Roberts J, etal. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 2002 17 349-355
27. Mann K, Croissant B. Konzepte der Alkoholismustherapie [Concepts of Alcoholism Therapy]. In: Singer MV, Theyssen S, Herausgeber Alkohol und Alkoholfolgekrankheiten. Grundlagen Diagnostik Therapie [Alcohol and Alcohol Sequelae. Principles Diagnostics Therapy] Berlin, Heidelberg, New York: Springer 2005 509-518
28. Martinotti G, Nicola M Di, Romanelli R, etal. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol 2007 22 149-156
29. Martinotti G, Romanelli R, Nicola M Di, etal. Oxcarbazepine at high dosages for the treatment of alcohol dependence. Am J Addict 2007 16 247-248
30. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 1997 278 144-151
31. Murphy DJ, Shaw GK, Clarke I. Tiaprid and Chlormethiazole in alcohol withdrawal: a double-blind trail. Alcohol Alcohol 1983 18 227-237
32. Peters DH, Faulds D. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 1994 47 1010-1032
33. Ponce G, Rodriguez-Jimenez R, Ortiz H, etal. Oxcarbazepine in the prevention of epileptic syndromes in alcohol detoxification. Rev Neurol 2005 40 577-580
34. Ritola E, Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981 64 254-259
35. Schaffer A, Naranjo CA. Recommended drug treatment strategies for the alcoholic patient. Drugs 1998 56 571-585
36. Schik G, Wedegaertner FR, Liersch J, etal. Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. Addict Biol 2005 10 283-288
37. Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav 2004 5 627-635
38. Seifert J, Peters E, Jahn K, etal. Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance-a pilot study. Addict Biol 2004 9 43-51
39. Shaw JM, Kolesar GS, Sellers EM, etal. Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1981 1 382-387
40. Soyka M, Morhart-Klute V, Horak M. A combination of carbamazepine/ tiapride in outpatient alcohol detoxification. Results from an open clinical study. Eur Arch Psychiatry Clin Neurosci 2002 252 197-200
41. Soyka M, Schmidt F, Schmidt P. Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence. Pharmacopsychiatry 2006 39 30-34
42. Soyka M, Tschner B, Clausius N. Neuroleptic treatment of alcohol hallucinosis: case series. Pharmacopsychiatry 2007 40 291-292
43. Sullivan JT, Sykora K, Schneiderman J, etal. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989 84 1353-1357
44. Thome J, Wiesbeck GA, Vince GH. Carbamazepine in treatment of alcohol withdrawal syndrome an overview of current research. Fortschr Neurol Psychiatr 1994 62 125-133
45. Wellington K, Goa KL. Oxcarbazepine: an update of its efficacy in the management of epilepsy. CNS Drugs 2001 15 137-163
46. Wetterling T, Veltrup C. Diagnostik und Therapie von Alkoholproblemen Berlin: Springer Verlag 1997
47. Wetterling T, Weber B, Depfenhart M, etal. Development of a rating scale to predict the severity of withdrawal syndrome. Alcohol Alcohol 2006 41 611-615